financetom
Business
financetom
/
Business
/
BHEL bags Rs 840 crore order for emission control equipment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BHEL bags Rs 840 crore order for emission control equipment
Jun 23, 2019 9:30 AM

State-owned BHEL Sunday said it has won an order worth Rs 840 crore from an NTPC subsidiary for emission control equipment.

Share Market Live

NSE

The company has bagged the order from Nabinagar Power Generating Company Ltd (NPGCL).

The order involves supply and installation of Flue Gas Desulphurization (FGD) system for control of sulphur oxides emissions at the 3x660 MW Nabinagar project in Aurangabad district of Bihar, a BHEL statement said.

With this order, the company is presently executing FGD systems for 23 units of NTPC and its joint ventures.

Overall, BHEL has contracted FGD orders for 37 units from various customers to date.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Stories at Midday: Tesla's Germany Plant Halts Production; Instagram, Facebook Down; Target Rises After Higher Fiscal Q4 Earnings, Sales; Apple's iPhone Sales Slip in China
Top Stories at Midday: Tesla's Germany Plant Halts Production; Instagram, Facebook Down; Target Rises After Higher Fiscal Q4 Earnings, Sales; Apple's iPhone Sales Slip in China
Mar 5, 2024
12:15 PM EST, 03/05/2024 (MT Newswires) -- Wall Street's major market averages were in the red Tuesday afternoon ahead of the Federal Reserve chairman's appearances before Congress this week. Chair Powell's two-day semi-annual monetary policy testimony is set to begin Wednesday. Tesla (TSLA) fell 4.5% in recent trading after several media outlets reported that the company had halted production in...
CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients
CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients
Mar 5, 2024
CASI Pharmaceuticals Inc ( CASI ) and BioInvent International AB announced preliminary efficacy data for BI-1206 in combination with rituximab in patients with relapsed/refractory (R/R) indolent Non-Hodgkin’s Lymphoma (iNHL) in the ongoing development program in China. The Phase 1 dose-escalation study showed signs of clinical efficacy, with four partial responses (PR) and one complete response (CR) out of eight evaluable patients.  The results...
Whitestone REIT Increases Monthly Dividends by 3%
Whitestone REIT Increases Monthly Dividends by 3%
Mar 5, 2024
12:14 PM EST, 03/05/2024 (MT Newswires) -- Whitestone REIT ( WSR ) said Tuesday it increased its monthly dividend to $0.04125 per share from $0.04. The higher dividend will be paid April 11, May 14 and June 13 to shareholders of record April 2, May 2 and June 4, respectively. Price: 12.28, Change: -0.03, Percent Change: -0.24 ...
Pet Valu Declines More Than 4%, TD Points to Investor Concerns
Pet Valu Declines More Than 4%, TD Points to Investor Concerns
Mar 5, 2024
12:09 PM EST, 03/05/2024 (MT Newswires) -- Pet Valu Holdings Ltd. ( PTVLF ) declined more than 4% on Tuesday. The Canadian pet food and supply retailer reported Q4 results before market open. With the mid-point of 2024 EBITDA/EPS guidance coming in 2%/4% below consensus, should push the shares a little lower today, TD Securities analyst Michael Van Aelst said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved